-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CwIKFzyGLhEUxfStkW1/lJOgZpq5DJrpuN3fnRmOaDpfmaeTx3lZR5p+gkinymVl GNqTSxRzXN+e24Up2k9cpA== 0000200406-08-000102.txt : 20080701 0000200406-08-000102.hdr.sgml : 20080701 20080701181520 ACCESSION NUMBER: 0000200406-08-000102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080630 FILED AS OF DATE: 20080701 DATE AS OF CHANGE: 20080701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foster-Cheek Kaye I CENTRAL INDEX KEY: 0001312622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 08931150 BUSINESS ADDRESS: BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0114 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2008-06-30 0000200406 JOHNSON & JOHNSON JNJ 0001312622 Foster-Cheek Kaye I JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 1 0 0 VP, Human Resources Common 647 D Common 2008-05-30 5 J 0 71 A 905 I 401(k) and ESOP Savings Plans Phantom Stock Units 2008-06-30 4 J 0 30 0 A Common Stock 30 4164 D Includes shares acquired under Issuer's Dividend Reinvestment Program. Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (05/30/2008). The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2008 at $64.06 per share are to be settled in cash upon the Reporting Person's Retirement. The Phantom Stock converts into common stock on a one-for-one basis. Linda King, as Attorney-in-Fact for Kaye I. Foster-Cheek 2008-06-30 -----END PRIVACY-ENHANCED MESSAGE-----